Optimal management of people with type 2 diabetes has increased in complexity over the last several years. The focus is not only on the management of hyperglycemia, but also on interventions that have been associated with a reduction in the development and progression of complications such as cardiovascular disease and chronic kidney disease. This program is focused on providing clinicians with a quick update on the optimal management of individuals with type 2 diabetes with chronic kidney disease or at high-risk of cardiovascular disease. This case-based practical program will provide healthcare professionals with a quick update on these topics to allow them to apply evidence-informed care in practice.
Diabetes, Medication Management
Beyond Glycemic Management: The Pharmacist’s Role in Optimizing Cardiovascular and Renal Outcomes in People with Type 2 Diabetes
Managing type 2 diabetes has increased in complexity over the last several years. This case-based practical program is designed to provide healthcare professionals with a quick update on the optimal management of people with type 2 diabetes who have chronic kidney disease or are at high-risk of cardiovascular disease.
DURATION
30 min
PROFESSION
Pharmacy
# OF CREDITS
1.5
ACCREDITATION
CCCEP
EXPIRY DATE
2025-10-01
Optimal management of people with type 2 diabetes has increased in complexity over the last several years. The focus is not only on the management of hyperglycemia, but also on interventions that have been associated with a reduction in the development and progression of complications such as cardiovascular disease and chronic kidney disease. This program is focused on providing clinicians with a quick update on the optimal management of individuals with type 2 diabetes with chronic kidney disease or at high-risk of cardiovascular disease. This case-based practical program will provide healthcare professionals with a quick update on these topics to allow them to apply evidence-informed care in practice.
Faculty
- Ronald Goldenberg, MD, FRCPC, FACE
- Robert Hauptman, BMSc, MD, MCFP
- Sofia Nastis, BMSc, MD, CCFP
- Jahan Lakhani, MD, CCFP
- Bilal Hatoum, BSc Pharm, RPh, APA, CDE
- Susie Jin, RPh, CDE, CRE
Learning objectives
Upon successful completion of this continuing education activity, you will be better able to:
- Analyze the components of the ABCDESSS approach in managing individuals with type 2 diabetes at high risk for cardiovascular disease
- Create treatment plans for adults with type 2 diabetes and chronic kidney disease or cardiovascular risk factors, integrating pharmacological interventions, lifestyle modifications, and regular monitoring strategies
- Evaluate the appropriateness of using SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists in adults with type 2 diabetes and chronic kidney disease, based on current evidence and guideline recommendations
- Apply evidence-based strategies to adjust antihyperglycemic agents and manage potential side effects in people with type 2 diabetes and varying levels of renal function
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.5 CEU(s).
CCCEP File Number: 1066-2024-3857-I-P.
Cost of course:
Free
# of credits: 1.5
Duration: 30 min